REMEVi review
A year, or $80 more
$199 semaglutide and $269 tirzepatide are 52-week plan rates. Month to month runs $279 and $339.
Our verdict
The gap between committing and not is $80 a month on semaglutide and $70 on tirzepatide, which is a real decision rather than a nudge. What REMEVi does well is publish both figures and state that the price holds through titration, so neither the plan term nor the dose ladder can surprise you later. The rates themselves sit above the middle of this market on either route.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- compounded semaglutide
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 51
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Pharmacy
- Not named
- Availability
- 51 jurisdictions
- Updated
- September 2026
What it is
A telehealth service across 51 jurisdictions prescribing compounded semaglutide and tirzepatide by weekly injection, sold on a 52-week plan or month to month.
How it works
Prescription-gated telehealth with two commitment lengths and a stated policy that the monthly figure does not change as the dose escalates.
Pricing transparency
Semaglutide: $199 a month on the 52-week plan, $279 month to month. Tirzepatide: $269 on the plan, $339 month to month. REMEVi states the price is the same every month with no titration increases.
Branded vs compounded
Compounded semaglutide and tirzepatide. Compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, efficacy or quality before dispensing.
Pros and watch-outs
What we like
- Both the plan rate and the month-to-month rate are published
- States explicitly that the price does not rise with the dose
- 51 jurisdictions
- $70 step between molecules is moderate for this market
Watch-outs
- The headline figure needs 52 weeks committed
- $279 month to month is above the middle of this market
- Injection only
- Compounding pharmacy is not named
Best for
Buyers who will commit a year and want the ladder policy in writing.
Who should look elsewhere
Anyone paying monthly, where the same treatment costs $80 more.
How REMEVi compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A discounted rate, if it lasts
See SkinnyRx → - Bodybuilding Health+
A headline that is the month-to-month rate
See Bodybuilding Health+ → - Oak
Flat dose pricing without a subscription
See Oak →
More compounded semaglutide sellers reviews: BetterMe RxBig Easy Weight LossBioGlow HealthbmiMDBon HealthCalibrate Health
Evidence & trials · Reviewed and last verified September 2026
How we assessed this. This review reflects GLP Loss’s own read of REMEVi’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does REMEVi cost without a commitment?
- $279 a month for semaglutide and $339 for tirzepatide. The advertised $199 and $269 are 52-week plan rates, so the gap between the two routes is $80 and $70 a month respectively.
- Does the price go up as my dose increases?
- No. REMEVi states the price is the same every month with no titration increases. Since semaglutide escalates over the first months by design, that policy is usually worth more across a year than a lower opening figure elsewhere.
- Is a 52-week plan worth it here?
- $199 against $279 is $960 across a year. Both drugs regain weight after withdrawal, so a year is a realistic horizon — but it is a year paid on a plan, and the cancellation terms are the thing to establish before starting.
- How does REMEVi compare on price?
- Above the middle of the field on both molecules at the monthly rate, and closer to the middle on the plan rate. Its distinguishing feature is disclosure rather than price.
- Is REMEVi legit?
- REMEVi is a compounded semaglutide sellers service. Its stated availability: 51 jurisdictions. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is REMEVi expensive compared with other compounded semaglutide sellers providers?
- REMEVi publishes a starting figure of $199/mo. Across the 115 compounded semaglutide sellers providers we review that publish a single monthly figure, those run $76 to $369 with a median of $170, which puts REMEVi above the median. The other 5 compounded semaglutide sellers providers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.